HOME >> BIOLOGY >> NEWS
Setting sights on the drugs of the future

Researchers at the University of Nottingham have joined forces with one of the worlds leading pharmaceutical companies, AstraZeneca, to single out potential medicines of the future.

In a unique collaboration between academia and the pharmaceutical industry, teams of experts from both sides gathered together at an ideas generation event, designed specifically to identify new areas for research into treatments that can be targeted at cancer, arthritis, cardio-pulmonary disease and other conditions.

The partnership underlines the significance of the EPSRC (Engineering and Physical Sciences Research Council)/AstraZeneca Doctoral Training Centre at the University, set up in 2006 as a direct collaboration with an industry partner to help develop pioneering treatments based on targeted therapeutics regarded as one of the significant future areas in 21st century medicine and in which The University of Nottingham is a UK leader.

The principle behind targeted therapeutics is to send medicines to the parts of the body where they are most needed, at the right time and in the right dose. In this way, diseased sites can be attacked directly, while healthy cells are bypassed, increasing the efficacy of the treatment and reducing side effects.

The Universitys 2.5 million EPSRC/AstraZeneca Doctoral Training Centre is training 25 of the UKs most promising pharmacy PhD students over the next five years in targeted therapeutics. Some of these PhD projects will now focus on ideas generated by the recent ideas generation event with AstraZeneca. The ideas which came out of the day-and-a-half meeting, focused on a range of topics including chemistry of new drug delivery systems, biophysical analysis of dosage forms, process analytical technologies and cellular transport of drugs and drug carriers.

Dr Amanda Zeffman, Project Officer, said that the event was one of the first such meetings to take place between academics and scientists fro
'"/>

Contact: Amanda Zeffman
44-011-595-14136
University of Nottingham
29-Mar-2007


Page: 1 2

Related biology news :

1. Setting the stage to find drugs against SARS
2. Setting the standard for computer models of life
3. Scientists gain important insights into acute promyelocytic leukemia
4. Variant CJD -- Prion amplification breakthrough brings new insights and hopes for a blood test
5. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
6. New insights into the neural basis of anxiety
7. From ink to optics, study of particle mixtures yields fundamental insights
8. Understanding the global carbon budget -- Woods Hole Research Center expert provides insights
9. A rainbow of methods promises insights into biological processes and diseases
10. New imaging approach promises insights into multiple sclerosis
11. Insights into osteosarcoma in cats and dogs may improve palliative care

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... ... and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the ... PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall vision. ...
(Date:6/23/2020)... Md. (PRWEB) , ... June ... ... leading provider of gene-to-protein and monoclonal antibody development services, today announced that ... protein-based products and services to the pharmaceutical, diagnostics, and research industries. The ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ORLANDO, Fla. (PRWEB) , ... June 23, 2020 ... ... proximity enabled solutions in complex indoor environments, announced today that Derek Fournier has ... the role of Chairman of the Board, effective immediately. , “DeCurtis Corporation ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen ... will be presented June 22-24 during the American Association for Cancer Research Virtual ... other profiles the potent, consistent single agent activity in KEAP1 mutant tumor models ...
(Date:6/19/2020)... ... 18, 2020 , ... The Vitaspace project was founded by the ... radically prolong life and find a way (medicine or technology) that will help to ... by various scientists from all over the world, doctors, and all people who care. ...
(Date:6/11/2020)... ... 2020 , ... PathSensors Inc., a Baltimore biotechnology company, announced ... program funded by the National Institute of Food and Agriculture (NIFA) entitled “Food ... goal was to engineer and develop a field-deployable instrument for portable pathogen and ...
Breaking Biology Technology:
Cached News: